This content is from: Premium
Ackman’s Pershing Square Not Backing Down from Herbalife Short
The activist sold Valeant but is keeping his other high-profile losing investment.
Bill Ackman, Pershing Square Capital Management (Bloomberg) Now that Bill Ackman has unloaded his huge losing stake in Valeant Pharmaceuticals International, is he going to finally close out his losing, high-profile negative bet on Herbalife? After all, since his epic 3.5-hour, 334-slide public case for shorting the multi-level marketer of nutrition products
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.